94
Views
11
CrossRef citations to date
0
Altmetric
Original

Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model

, , , , &
Pages 853-858 | Accepted 22 Jun 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vicki Morrison. (2006) Myeloid growth factors: To use or not to use, that is the question. Leukemia & Lymphoma 47:5, pages 780-782.
Read now

Articles from other publishers (10)

Yu Zhu, Daihong Guo, Xianghao Kong, Siyuan Liu & Chengxuan Yu. (2022) A Risk-Prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-Based Chemotherapy in Cancer Patients: A Retrospective Cohort Study. Pharmacology 107:1-2, pages 69-80.
Crossref
M. S. Hardianti, S. A. Setiawan, M. R. Bagaskoro, N. Anggorowati, I. Purwanto, K. W. Taroeno-Hariadi, J. Kurnianda & S. H. Hutajulu. (2021) Risk Factors for Neutropenia after the First Cycle of Chemotherapy for Non-Hodgkin Lymphoma. European Journal of Medical and Health Sciences 3:6, pages 73-77.
Crossref
Takumi Sakurada, Sanako Bando, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Mitsuhiro Goda, Yasushi Kirino, Toshimi Nakamura, Kazuhiko Teraoka, Masami Morimoto, Akira Tangoku & Keisuke Ishizawa. (2019) Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study. Cancer Chemotherapy and Pharmacology 84:5, pages 1107-1114.
Crossref
Sibylle Schirm, Christoph Engel, Markus Loeffler & Markus Scholz. (2014) Modelling chemotherapy effects on granulopoiesis. BMC Systems Biology 8:1.
Crossref
Ryoichi Yano. (2014) Risk Factors of Severe Neutropenia during Cancer Chemotherapy. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 40:6, pages 317-333.
Crossref
Juan José Alonso, Araceli Cánovas, José Guillermo Barreiro & Ciriaco Aguirre. (2012) Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas. European Journal of Internal Medicine 23:3, pages 255-260.
Crossref
Ruth Pettengell, André Bosly, Thomas D. Szucs, Christian Jackisch, Robert Leonard, Robert Paridaens, Manuel Constenla & Matthias Schwenkglenks. (2009) Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study. British Journal of Haematology 144:5, pages 677-685.
Crossref
M. Moreau, J. Klastersky, A. Schwarzbold, F. Muanza, A. Georgala, M. Aoun, A. Loizidou, M. Barette, S. Costantini, M. Delmelle, L. Dubreucq, M. Vekemans, A. Ferrant, D. Bron & M. Paesmans. (2009) A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Annals of Oncology 20:3, pages 513-519.
Crossref
Lew M. IacovelliBrandy L. Persson. (2008) Management of Chemotherapy-Induced Neutropenia: Opportunities for Pharmacist Involvement. Hospital Pharmacy 43:6, pages 472-484.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.